These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 12579971

  • 1. [Synthesis and determination for enantiomeric purity of 6-fluoro-L-DOPA].
    Tang GH, Zhang L, Tang XL, Wang YX, Yin DZ.
    Yao Xue Xue Bao; 2001 Oct; 36(10):739-42. PubMed ID: 12579971
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. No-carrier-added regioselective preparation of 6-[18F]fluoro-L-dopa.
    Lemaire C, Guillaume M, Cantineau R, Christiaens L.
    J Nucl Med; 1990 Jul; 31(7):1247-51. PubMed ID: 2113943
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Production at the Curie level of no-carrier-added 6-18F-fluoro-L-dopa.
    Libert LC, Franci X, Plenevaux AR, Ooi T, Maruoka K, Luxen AJ, Lemaire CF.
    J Nucl Med; 2013 Jul; 54(7):1154-61. PubMed ID: 23658219
    [Abstract] [Full Text] [Related]

  • 7. High yield synthesis of 6-[18F]fluoro-L-dopa by regioselective fluorination of protected L-dopa with [18F]acetylhypofluorite.
    Chaly T, Diksic M.
    J Nucl Med; 1986 Dec; 27(12):1896-901. PubMed ID: 3097278
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficient synthesis of the 18F-labelled 3-O-methyl-6-[18F]fluoro-L-DOPA.
    Füchtner F, Steinbach J.
    Appl Radiat Isot; 2003 May; 58(5):575-8. PubMed ID: 12735974
    [Abstract] [Full Text] [Related]

  • 10. Aspects of 6-[18F]fluoro-L-DOPA preparation: precursor synthesis, preparative HPLC purification and determination of radiochemical purity.
    Füchtner F, Angelberger P, Kvaternik H, Hammerschmidt F, Simovc BP, Steinbach J.
    Nucl Med Biol; 2002 May; 29(4):477-81. PubMed ID: 12031883
    [Abstract] [Full Text] [Related]

  • 11. Robotic synthesis of 6-[18F]fluoro-L-dopa.
    Chang CW, Wang HE, Lin HM, Chtsai CS, Chen JB, Liu RS.
    Nucl Med Commun; 2000 Sep; 21(9):799-802. PubMed ID: 11065151
    [Abstract] [Full Text] [Related]

  • 12. A new precursor for the preparation of 6-[18F]Fluoro-L-m-tyrosine ([18F]FMT): efficient synthesis and comparison of radiolabeling.
    VanBrocklin HF, Blagoev M, Hoepping A, O'Neil JP, Klose M, Schubiger PA, Ametamey S.
    Appl Radiat Isot; 2004 Dec; 61(6):1289-94. PubMed ID: 15388123
    [Abstract] [Full Text] [Related]

  • 13. New synthesis of fluorine-18-labeled 6-fluoro-L-dopa by cleaving the carbon-silicon bond with fluorine.
    Diksic M, Farrokhzad S.
    J Nucl Med; 1985 Nov; 26(11):1314-8. PubMed ID: 3932611
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans.
    Cumming P, Léger GC, Kuwabara H, Gjedde A.
    J Cereb Blood Flow Metab; 1993 Jul; 13(4):668-75. PubMed ID: 8314919
    [Abstract] [Full Text] [Related]

  • 17. Blood-brain transfer and metabolism of 6-[18F]fluoro-L-dopa in rat.
    Reith J, Dyve S, Kuwabara H, Guttman M, Diksic M, Gjedde A.
    J Cereb Blood Flow Metab; 1990 Sep; 10(5):707-19. PubMed ID: 2117017
    [Abstract] [Full Text] [Related]

  • 18. Metabolites of 6-[18F]fluoro-L-dopa in human blood.
    Firnau G, Sood S, Chirakal R, Nahmias C, Garnett ES.
    J Nucl Med; 1988 Mar; 29(3):363-9. PubMed ID: 3126278
    [Abstract] [Full Text] [Related]

  • 19. Aspects of 6-[18F]fluoro-L-DOPA preparation. Deuterochloroform as a substitute solvent for Freon 11.
    Füchtner F, Zessin J, Mäding P, Wüst F.
    Nuklearmedizin; 2008 Mar; 47(1):62-4. PubMed ID: 18278215
    [Abstract] [Full Text] [Related]

  • 20. Catalytic enantioselective synthesis of 18F-fluorinated alpha-amino acids under phase-transfer conditions using (S)-NOBIN.
    Krasikova RN, Zaitsev VV, Ametamey SM, Kuznetsova OF, Fedorova OS, Mosevich IK, Belokon YN, Vyskocil S, Shatik SV, Nader M, Schubiger PA.
    Nucl Med Biol; 2004 Jul; 31(5):597-603. PubMed ID: 15219278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.